VBLT - Vascular Biogenics Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
599
585
13,864
0
0
Cost of Revenue
179
235
340
-
0
Gross Profit
420
350
13,524
-
0
Operating Expenses
Research Development
14,322
15,940
17,770
12,447
11,198
Selling General and Administrative
4,994
5,547
6,359
3,786
3,639
Total Operating Expenses
19,386
21,557
24,179
16,275
14,871
Operating Income or Loss
-18,966
-21,207
-10,655
-16,275
-14,871
Interest Expense
-
-
-
-
117
Total Other Income/Expenses Net
-
-122
209
22
-101
Income Before Tax
-18,097
-20,458
-10,138
-16,002
-14,888
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-18,097
-20,458
-10,138
-16,002
-14,888
Net Income
-18,097
-20,458
-10,138
-16,002
-14,888
Net Income available to common shareholders
-18,097
-20,458
-10,138
-16,002
-14,888
Reported EPS
Basic
-
-0.62
-0.37
-0.64
-0.73
Diluted
-
-0.62
-0.37
-0.64
-0.73
Weighted average shares outstanding
Basic
-
32,969
27,398
24,971
20,310
Diluted
-
32,969
27,398
24,971
20,310
EBITDA
-
-20,051
-10,499
-16,145
-14,749